Prophylactic Administration of Mesenchymal Stromal Cells Does Not Prevent Arrested Lung Development in Extremely Premature-Born Non-Human Primates

Premature birth is a leading cause of childhood morbidity and mortality and often followed by an arrest of postnatal lung development called bronchopulmonary dysplasia. Therapies using exogenous mesenchymal stromal cells (MSC) have proven highly efficacious in term-born rodent models of this disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Möbius, Marius A, Seidner, Steven R, McCurnin, Donald C, Menschner, Leonhard, Fürböter-Behnert, Isabel, Schönfeld, Julia, Marzahn, Jenny, Freund, Daniel, Münch, Nadine, Hering, Sandra, Mustafa, Shamimunisa B, Anzueto, Diana G, Winter, Lauryn A, Blanco, Cynthia L, Hanes, Martha A, Rüdiger, Mario, Thébaud, Bernard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Fetal and Neonatal Stem Cells
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985113/
https://www.ncbi.nlm.nih.gov/pubmed/36724000
http://dx.doi.org/10.1093/stcltm/szac088

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985113/
https://www.ncbi.nlm.nih.gov/pubmed/36724000
http://dx.doi.org/10.1093/stcltm/szac088

Ejemplares similares